UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pertuzumab: new hope for patients with HER2-positive breast cancer

Annals of oncology, 2013-02, Vol.24 (2), p.273-282

2013

Volltextzugriff (PDF)

Febrile Neutropenia Rates According to Body Mass Index and Dose Capping in Women Receiving Chemotherapy for Early Breast Cancer

Clinical oncology (Royal College of Radiologists (Great Britain)), 2016-09, Vol.28 (9), p.597-603

2016

Volltextzugriff (PDF)

Complications of hyperglycaemia with PI3K–AKT–mTOR inhibitors in patients with advanced solid tumours on Phase I clinical trials

British journal of cancer, 2015-12, Vol.113 (11), p.1541-1547

2015

Volltextzugriff (PDF)

Rates of major complications during neoadjuvant and adjuvant chemotherapy for early breast cancer: An off study population

Breast (Edinburgh), 2016-12, Vol.30, p.13-18

2016

Volltextzugriff (PDF)

Pathologic Response Rates Following Neoadjuvant Anthracycline and Taxane-based Chemotherapy for Early Breast Cancer (EBC)

Clinical oncology (Royal College of Radiologists (Great Britain)), 2017-06, Vol.29 (6), p.e103-e103

2017

Volltextzugriff (PDF)

Epidermal growth factor receptor and epididymis invasion as prognostic biomarkers in clinical stage I testicular germ cell tumours

Journal of translational medicine, 2017-03, Vol.15 (1), p.62-62, Article 62

2017

Volltextzugriff (PDF)

Febrile Neutropenia Rates According to BMI and Dose-capping: a Retrospective Analysis in a Tertiary Referral Centre

Clinical oncology (Royal College of Radiologists (Great Britain)), 2016-05, Vol.28 (5), p.e5-e5

2016

Volltextzugriff (PDF)

Rates of Venous Thromboembolism (VTE) and Other Major Complications During Peri-operative Chemotherapy (CT) for Early Breast Cancer (EBC) in an Off-study Population

Clinical oncology (Royal College of Radiologists (Great Britain)), 2016-05, Vol.28 (5), p.e7-e7

2016

Volltextzugriff (PDF)

Controversial issues in early-stage breast cancer: a global collaborative survey, supported by the European Society for Medical Oncology (ESMO)

Annals of oncology, 2014-08, Vol.25 (8), p.1558-1562

2014

Volltextzugriff (PDF)

339 Clinical outcome and prognostic factors of patients (pts) with relapsed mesothelioma on phase I trials in the Drug Development Unit (DDU) of the Royal Marsden Hospital (RMH)

European journal of cancer (1990), 2015-09, Vol.51, p.S67-S67

2015

Volltextzugriff (PDF)

Lanreotide in Metastatic Enteropancreatic Neuroendocrine Tumors

The New England journal of medicine, 2014-07, Vol.371 (3), p.224-233

2014

Volltextzugriff (PDF)

ENETS Consensus Guidelines Update for the Management of Distant Metastatic Disease of Intestinal, Pancreatic, Bronchial Neuroendocrine Neoplasms (NEN) and NEN of Unknown Primary Site

Neuroendocrinology, 2016-01, Vol.103 (2), p.172-185

2016

Volltextzugriff (PDF)

ENETS Consensus Guidelines Update for Gastroduodenal Neuroendocrine Neoplasms

Neuroendocrinology, 2016-01, Vol.103 (2), p.119-124

2016

Volltextzugriff (PDF)

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Radiological, Nuclear Medicine and Hybrid Imaging

Neuroendocrinology, 2017-01, Vol.105 (3), p.212-244

2017

Volltextzugriff (PDF)

396 (PB-029) - Treatment with eribulin in HER2-negative breast cancer patients with brain metastases: Experience at Vall d’ Hebron University Hospital

European journal of cancer (1990), 2018-04, Vol.92, p.S114-S114

2018

Volltextzugriff (PDF)

Treatment with eribulin in HER2-negative breast cancer patients with brain metastases: Experience at Vall d’ Hebron University Hospital

European journal of cancer (1990), 2018-04, Vol.92, p.S114

2018

Volltextzugriff (PDF)

ENETS Consensus Guidelines Update for Colorectal Neuroendocrine Neoplasms

Neuroendocrinology, 2016-01, Vol.103 (2), p.139-143

2016

Volltextzugriff (PDF)

Recommendations for management of patients with neuroendocrine liver metastases

The lancet oncology, 2014, Vol.15 (1), p.e8-e21

2014

Volltextzugriff (PDF)

Anti-tumour effects of lanreotide for pancreatic and intestinal neuroendocrine tumours: the CLARINET open-label extension study

Endocrine-related cancer, 2016-03, Vol.23 (3), p.191-199

2016

Volltextzugriff (PDF)

ENETS Consensus Guidelines for Neuroendocrine Neoplasms of the Appendix (Excluding Goblet Cell Carcinomas)

Neuroendocrinology, 2016-01, Vol.103 (2), p.144-152

2016

Volltextzugriff (PDF)

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Pathology - Diagnosis and Prognostic Stratification

Neuroendocrinology, 2017-01, Vol.105 (3), p.196-200

2017

Volltextzugriff (PDF)

Clinical Outcome of Advanced Non-Small Cell Lung Cancer Patients (Ansclc Pts) on Phase I Trials in the Drug Development Unit (Ddu) at the Royal Marsden Hospital (Rmh)

Annals of oncology, 2014-09, Vol.25, p.iv434

2014

Volltextzugriff (PDF)

1241PCLINICAL OUTCOME OF ADVANCED NON-SMALL CELL LUNG CANCER PATIENTS (ANSCLC PTS) ON PHASE I TRIALS IN THE DRUG DEVELOPMENT UNIT (DDU) AT THE ROYAL MARSDEN HOSPITAL (RMH)

Annals of oncology, 2014-09, Vol.25 (suppl_4), p.iv434-iv434

2014

Volltextzugriff (PDF)

ENETS Consensus Recommendations for the Standards of Care in Neuroendocrine Neoplasms: Follow-Up and Documentation

Neuroendocrinology, 2017-01, Vol.105 (3), p.310-319

2017

Volltextzugriff (PDF)

Tumor growth rate as a metric of progression, response, and prognosis in pancreatic and intestinal neuroendocrine tumors

BMC cancer, 2019-01, Vol.19 (1), p.66-66, Article 66

2019

Volltextzugriff (PDF)

1 – 25 von 60

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(60)
Mit Volltextzugriff
(52)

Publikationsform

Artikel
(60)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(34)
Science & Technology
(34)
Humans
(31)
Endocrinology & Metabolism
(12)
Female
(11)
Neurosciences
(11)
Neurosciences & Neurology
(11)
Radiology
(11)
Oncology
(10)
Male
(9)
Neuroendocrine Tumors - Therapy
(9)
Adult
(8)
Aged
(8)
Care And Treatment
(8)
Hematology, Oncology And Palliative Medicine
(8)
Middle Aged
(8)
Neuroendocrine Tumors - Diagnosis
(7)
Tumors
(7)
Antineoplastic Agents - Adverse Effects
(6)
Cardiovascular System & Cardiology
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pertuzumab: new hope for patients with HER2-positive breast cancer

Febrile Neutropenia Rates According to Body Mass Index and Dose Capping in Women Receiving Chemotherapy for Early Breast Cancer

Complications of hyperglycaemia with PI3K–AKT–mTOR inhibitors in patients with advanced solid tumours on Phase I clinical trials

Rates of major complications during neoadjuvant and adjuvant chemotherapy for early breast cancer: An off study population

Pathologic Response Rates Following Neoadjuvant Anthracycline and Taxane-based Chemotherapy for Early Breast Cancer (EBC)

Epidermal growth factor receptor and epididymis invasion as prognostic biomarkers in clinical stage I testicular germ cell tumours

Febrile Neutropenia Rates According to BMI and Dose-capping: a Retrospective Analysis in a Tertiary Referral Centre

Rates of Venous Thromboembolism (VTE) and Other Major Complications During Peri-operative Chemotherapy (CT) for Early Breast Cancer (EBC) in an Off-study Population

Controversial issues in early-stage breast cancer: a global collaborative survey, supported by the European Society for Medical Oncology (ESMO)

339 Clinical outcome and prognostic factors of patients (pts) with relapsed mesothelioma on phase I trials in the Drug Development Unit (DDU) of the Royal Marsden Hospital (RMH)

Lanreotide in Metastatic Enteropancreatic Neuroendocrine Tumors

ENETS Consensus Guidelines Update for the Management of Distant Metastatic Disease of Intestinal, Pancreatic, Bronchial Neuroendocrine Neoplasms (NEN) and NEN of Unknown Primary Site

ENETS Consensus Guidelines Update for Gastroduodenal Neuroendocrine Neoplasms

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Radiological, Nuclear Medicine and Hybrid Imaging

396 (PB-029) - Treatment with eribulin in HER2-negative breast cancer patients with brain metastases: Experience at Vall d’ Hebron University Hospital

Treatment with eribulin in HER2-negative breast cancer patients with brain metastases: Experience at Vall d’ Hebron University Hospital

ENETS Consensus Guidelines Update for Colorectal Neuroendocrine Neoplasms

Recommendations for management of patients with neuroendocrine liver metastases

Anti-tumour effects of lanreotide for pancreatic and intestinal neuroendocrine tumours: the CLARINET open-label extension study

ENETS Consensus Guidelines for Neuroendocrine Neoplasms of the Appendix (Excluding Goblet Cell Carcinomas)

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Pathology - Diagnosis and Prognostic Stratification

Clinical Outcome of Advanced Non-Small Cell Lung Cancer Patients (Ansclc Pts) on Phase I Trials in the Drug Development Unit (Ddu) at the Royal Marsden Hospital (Rmh)

1241PCLINICAL OUTCOME OF ADVANCED NON-SMALL CELL LUNG CANCER PATIENTS (ANSCLC PTS) ON PHASE I TRIALS IN THE DRUG DEVELOPMENT UNIT (DDU) AT THE ROYAL MARSDEN HOSPITAL (RMH)

ENETS Consensus Recommendations for the Standards of Care in Neuroendocrine Neoplasms: Follow-Up and Documentation

Tumor growth rate as a metric of progression, response, and prognosis in pancreatic and intestinal neuroendocrine tumors

Suchergebnisse filtern